Balanced translocation in a patient with severe myoclonic epilepsy of infancy disrupts the sodium channel gene SCN1A

Epilepsia. 2008 Jun;49(6):1091-4. doi: 10.1111/j.1528-1167.2008.01550.x. Epub 2008 Feb 20.

Abstract

In a patient with severe myoclonic epilepsy of infancy (SMEI), we identified a de novo balanced translocation, t(2;5)(q24.3,q34). The breakpoint on chromosome 2q24.3 truncated the SCN1A gene and the 5q34 breakpoint was within a highly conserved genomic region. Point mutations or microdeletions of SCN1A have previously been identified in SMEI patients, but this is the first report of a balanced translocation disrupting the SCN1A gene in an epilepsy patient. We therefore recommend that SMEI patients without SCN1A microdeletions or point mutations should be investigated for chromosomal rearrangements.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Brain / pathology
  • Child
  • Child, Preschool
  • Chromosome Breakage
  • Chromosome Deletion
  • Chromosomes, Human, Pair 2 / genetics*
  • Chromosomes, Human, Pair 5 / genetics*
  • Disease Progression
  • Epilepsies, Myoclonic / diagnosis
  • Epilepsies, Myoclonic / genetics*
  • Epilepsies, Myoclonic / pathology
  • Follow-Up Studies
  • Humans
  • Infant
  • Intellectual Disability / genetics
  • Intellectual Disability / pathology
  • Karyotyping
  • NAV1.1 Voltage-Gated Sodium Channel
  • Nerve Tissue Proteins / genetics*
  • Phenotype
  • Point Mutation
  • Sodium Channels / genetics*
  • Spasms, Infantile / diagnosis
  • Spasms, Infantile / genetics
  • Spasms, Infantile / pathology
  • Status Epilepticus / diagnosis
  • Status Epilepticus / genetics
  • Status Epilepticus / pathology
  • Translocation, Genetic / genetics*

Substances

  • NAV1.1 Voltage-Gated Sodium Channel
  • Nerve Tissue Proteins
  • SCN1A protein, human
  • Sodium Channels